Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breast Implant Patient Follow-Up Data Collection Crucial – FDA Guidance

This article was originally published in The Gray Sheet

Executive Summary

Breast implant manufacturers should offer incentives in order to encourage patient cooperation with post-implant study data collection efforts, FDA advises in a final guidance document

You may also be interested in...



NCI Silicone Breast Implant Study Will Assess Connective Tissue Disease

Follow-up analyses of a 13,500-patient silicone breast implant study will evaluate the relationship of the devices to connective tissue diseases (CTD), according to a 1report submitted to Congress by the National Institutes of Health April 24

NCI Silicone Breast Implant Study Will Assess Connective Tissue Disease

Follow-up analyses of a 13,500-patient silicone breast implant study will evaluate the relationship of the devices to connective tissue diseases (CTD), according to a 1report submitted to Congress by the National Institutes of Health April 24

FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002

Mentor and Inamed should reconvene focus groups to review patient labeling changes for saline-filled breast implants, FDA's General and Plastic Surgery Devices Panel recommended July 9 at its meeting in Gaithersburg, Maryland

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel